Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights
Abstract Temozolomide (TMZ) remains the cornerstone chemotherapy for glioma, yet intrinsic and acquired resistance mechanisms significantly limit its clinical effectiveness. This review summarizes the multifaceted molecular pathways contributing to TMZ resistance, including enhanced DNA repair mecha...
Saved in:
| Main Authors: | Hengzeng Li, Yahui Wu, Yue Chen, Jinquan Lv, Chengkang Qu, Tingjie Mei, Yunfan Zheng, Cheng Ye, Feifei Li, Shuo Ge, Anhui Yao, Liyun Jia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Acta Neuropathologica Communications |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40478-025-02046-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
99mTc-Tetrofosmin uptake correlates with the sensitivity of glioblastoma cell lines to temozolomide
by: George Alexiou, et al.
Published: (2017-01-01) -
Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma
by: Diego Carrillo-Beltrán, et al.
Published: (2025-01-01) -
Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas
by: Mengqian Huang, et al.
Published: (2025-03-01) -
The role of autophagy inhibition in the enhanced cytotoxicity of temozolomide on melanoma cell lines
by: O. O. Ryabaya, et al.
Published: (2017-10-01) -
Siramesine induced cell death of glioblastoma through inactivating the STAT3-MGMT signaling pathway
by: Xiaohang Cui, et al.
Published: (2025-07-01)